Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:EXAC Exactech (EXAC) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Exactech Stock (NASDAQ:EXAC) 30 days 90 days 365 days Advanced Chart Remove Ads Get Exactech alerts:Sign Up Key Stats Today's Range$49.25▼$49.3050-Day Range N/A52-Week Range$23.75▼$50.95Volume255,640 shsAverage Volume182,742 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewExactech, Inc. develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company's segments include knee, hip, biologics and spine, extremity and other products. Its other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines. The Company distributes joint replacement systems, including knee, hip, spine and extremity implant systems, and biologic products and services and bone cement materials used in orthopedic surgery and dental procedures. The Exactech Knee System provides solutions for partial, primary and revision total knee arthroplasty. Its hip solutions address the continuum of hip arthroplasty. It manufactures and distributes various products and services designed for the healing and regeneration of bone and soft tissue, including products, which contain human allograft.Read More… Remove Ads Receive EXAC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Exactech and its competitors with MarketBeat's FREE daily newsletter. Email Address EXAC Stock News HeadlinesExactech Secures Groundbreaking Patent, Paving the Way for the Next Generation of Personalized Surgical PlanningMarch 19 at 9:40 AM | finance.yahoo.comInvestment Firms Deemed Winning Bidder to Become Exactech's New OwnersMarch 11, 2025 | finance.yahoo.com$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.March 19, 2025 | Stansberry Research (Ad)Exactech Debuts New Implant Technology with First-to-Market GPS Navigation for Ankle SurgeryMarch 6, 2025 | finance.yahoo.comTexas A&M Aggies Stumble Down AP Poll as Losing Streak ContinuesMarch 5, 2025 | msn.comGator Nation in Full-Force During Weekend EventsMarch 5, 2025 | msn.comHow to watch Florida Gators: Live stream info, TV channel, game time | March 1March 1, 2025 | gatorswire.usatoday.comESPN's College GameDay heading to premier SEC showdown next SaturdayFebruary 23, 2025 | msn.comSee More Headlines EXAC Stock Analysis - Frequently Asked Questions How were Exactech's earnings last quarter? Exactech Inc (NASDAQ:EXAC) announced its earnings results on Monday, October, 30th. The medical equipment provider reported $0.20 earnings per share for the quarter, missing analysts' consensus estimates of $0.23 by $0.03. The medical equipment provider had revenue of $61.40 million for the quarter, compared to analysts' expectations of $61.78 million. What other stocks do shareholders of Exactech own? Based on aggregate information from My MarketBeat watchlists, some other companies that Exactech investors own include Immersion (IMMR), Verizon Communications (VZ), Bristol-Myers Squibb (BMY), Johnson & Johnson (JNJ), Meta Platforms (META), Riot Platforms (RIOT) and Allergan (AGN). Company Calendar Last Earnings10/30/2017Today3/19/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryHealth Care Equipment Current SymbolNASDAQ:EXAC CIK913165 Webwww.exac.com Phone+1-352-3771140FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The 10 Best Stocks to Own: Spring 2025Discover the 10 best stocks to own in Spring 2025, carefully selected for their growth potential amid market volatility. This exclusive report highlights top companies poised to thrive in uncertain economic conditions—download now to gain an investing edge.Get This Free Report This page (NASDAQ:EXAC) was last updated on 3/19/2025 by MarketBeat.com Staff From Our PartnersElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exactech Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Exactech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.